BC Life Sciences Companies Win at Canada's Top 10™ Competition LifeSciences BC is pleased to report that four of our member companies we nominated for the Red Herring Canada 2008 Competition did very well in this national competition.  Indel Therapeutics, iCo Therapeutics, and Innimex Pharmaceuticals all took one of the Canada's Top 10™ Competition winners' positions, and EnGene was listed as a finalist.  The competition showcases Canada's life sciences, cleantech and technology sectors. Working in partnership with Canadian Consulates in Boston, New York City, San Diego and San Francisco, winning companies will participate in targeted investment forums in each city, providing them with an opportunity to meet with Venture Capital investors who have expressed an active interest in financing these companies. Since its inception in 1999, competition alumni have secured more than $522M in venture capital financing.  More information about the competition can be found at  http://www.topcanadiancompanies.ca/. Top 10™ winners are chosen by an independent expert panel of Canadian and U.S. venture capitalists. The panel can be viewed at http://www.topcanadiancompanies.ca/jury/ls_jury.html. Congratulations to all!

send this to a friend unsubscrive © LifeSciences British Columbia. All rights reserved.

Suite 900 - 1188 West Georgia St. Vancouver, BC V6E 4A2